ImmuCell Corporation (ICCC)

ImmuCell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	51	46	39	47	62	43
Market Cap Growth	59.03%	16.33%	-16.51%	-23.70%	44.31%	15.59%
Enterprise Value	61	58	54	51	62	48
Last Close Price	5.64	5.15	5.09	6.10	8.00	5.95
PE Ratio	21.85	-	-	-	-	-
PS Ratio	1.83	1.73	2.26	2.55	3.22	2.80
PB Ratio	1.71	1.67	1.58	1.56	1.90	1.52
P/TBV Ratio	1.72	1.68	1.59	1.56	1.91	1.53
P/FCF Ratio	71.32	-	-	-	-	-
P/OCF Ratio	25.64	128.23	-	-	64.91	32.62
EV/Sales Ratio	2.19	2.17	3.10	2.76	3.22	3.13
EV/EBITDA Ratio	11.18	39.63	-	65.78	22.78	49.62
EV/EBIT Ratio	22.20	-	-	-	240.62	-
EV/FCF Ratio	84.91	-	-	-	-	-
Debt / Equity Ratio	0.46	0.55	0.67	0.41	0.32	0.38
Debt / EBITDA Ratio	2.29	7.75	-	12.96	3.57	9.69
Debt / FCF Ratio	19.02	-	-	-	-	-
Asset Turnover	0.62	0.60	0.39	0.42	0.45	0.39
Inventory Turnover	1.85	2.43	1.89	2.26	4.09	3.68
Quick Ratio	1.63	1.72	0.76	2.47	5.09	4.44
Current Ratio	4.21	3.41	2.73	4.56	6.42	5.50
Return on Equity (ROE)	8.27%	-8.21%	-20.86%	-7.92%	-0.26%	-3.57%
Return on Assets (ROA)	3.79%	-1.73%	-7.36%	-2.39%	0.38%	-2.18%
Return on Capital (ROIC)	4.01%	-1.83%	-7.72%	-2.49%	0.39%	-2.26%
Return on Capital Employed (ROCE)	6.60%	-3.00%	-13.20%	-4.10%	0.60%	-3.60%
Earnings Yield	4.55%	-4.70%	-14.64%	-5.28%	-0.13%	-2.38%
FCF Yield	1.40%	-0.24%	-16.64%	-11.68%	-2.67%	-6.42%
Buyback Yield / Dilution	-14.38%	-5.42%	-0.03%	-2.01%	-5.25%	-5.78%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q